Milton H. Werner Insider Profile
4 Followers
Milton H. Werner, President & CEO, Director at Inhibikase Therapeutics, holds 5.34M shares in Inhibikase Therapeutics (Ticker: IKT). Most recently, Milton H. Werner Bought 5,000 shares of Inhibikase Therapeutics on Aug 16, 2022 for an estimated value of $4.00K.
Milton H. Werner's Trading History
| IKTInhibikase Therapeutics | Aug 16, 2022 | President & CEO, Director | Informative Buy | 4.00K | $7.74M | |
IKT Insider Shares: 5.34M (21.15%) | ||||||
You May Also Like
Milton H. Werner insider profile FAQ
What is the percentage of profitable transactions made by Milton H. Werner?
The percentage of profitable transactions made by Milton H. Werner is 0%.
What is the average return per transaction made by Milton H. Werner?
The average return per transaction made by Milton H. Werner is -39.20%.
What stocks does Milton H. Werner hold?
Milton H. Werner holds: IKT stocks.
What was Milton H. Werner’s latest transaction?
Milton H. Werner’s latest transaction was an Informative Buy of $4.00K.
What was Milton H. Werner's most profitable transaction?
Milton H. Werner’s most profitable transaction was an Informative Buy of IKT stock on May 23, 2022. The return on the trade was -17.10%.
What is Milton H. Werner's role in Inhibikase Therapeutics?
Milton H. Werner's role in Inhibikase Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
